CHICAGO Last Wednesday and Thursday, a biotech family reunion took place at Navy Pier in Chicago when IBIO
, otherwise known as the Illinois Biotechnology Industry Organization, celebrated its fifth-annual event. The gathering was called iBIOMarketplace.
This event originally started in 1999 as the annual meeting of IBIOs predecessor orga......Full article >>>
ear for biotech and Chicagos economy, and even though the meeting looked like a biotech circus with three rings operating at the same time, attendance fell below expectations. It barely reached the 400 level. It was solid but still quite disappointing.
In retrospect, McCormick and the Hyatt were great for large groups of people coming from out of town, but for a local meeting, this site ......Full article >>>
thway to biotech growth in the region for the future. IBIOs chairman of the board for the year, James L. Tyree (a senior executive from Abbott Labs), also demonstrated the significant support by this company to biotech in Illinois.
I was very much swayed by Bruce Rauners powerful message of how GTCRs $6 billion in funds help build companies all over the U.S. and GTCRs unique style for as......Full article >>>
et cap of $258 billion, which isnt too far from the combined value of Pfizer
(Big Pharmas largest companies). He also stated that the biotech industry has 130 drugs on the market and 350 drugs either awaiting FDA approval or in human clinical trials. He noted another trend: the appearance......Full article >>>
l the Baxter corporate culture a biotech culture. Still, this is one of Illinoiss largest health-care companies and I watch their moves assiduously.
iBIOMarketplace also featured presentations by about 20 biotech companies (public and private) mostly from the Midwest (one did come all the way from the Bay area and another came from India). These presentations were not only well attended;......Full article >>>
lace in the first part of 2004, which will hopefully provide an opportunity for VC money to exit long-held investments and renew their portfolios with new investments.
Seven biotech companies went public during the month between Oct. 8 and Nov. 6 raising $268 million, according to BioCentury. Most of the pricing of these IPOs was on the low end of the pricing range, which shows that the ......Full article >>>
Source:wistechnology.com By Michael Rosen 11/19/03Related biology technology :1
. Biotech officials praise focus of new venture fund2
. Biotech executive books a career flight thats closer to home3
. Gala Biotech among companies sold for $3.3 billion4
. Biotech with Madison ties raises $21M in capital5
. Biotech firm uses live heart tissue in drug screens6
. Biotech talent drew venture-funded firm to Madison7
. Biotech firm has strokes, Alzheimers in its sights8
. 42 days until the 2006 Olympics of Biotechnology in Chicago9
. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled10
. Biotech leads list of top U.S. companies to work for11
. Biotech flourishes in 2005 while Big Pharma is on the decline